A list of downloadable documents created during development.
Pulmonary embolism (acute treatment, VTE prevention): rivaroxaban equality impact assessment - guidance review
Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: final appraisal determination
Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: appendix B - Final scope
Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: appendix C - Final matrix
Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: appendix D - scope consultation comments table
Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: equality impact assessment form
Pulmonary embolism (acute treatment, VTE prevention - rivaroxaban: appendix A draft scope for consultation (post referral) October 2012
Pulmonary embolism (acute treatment, VTE prevention - rivaroxaban: appendix B draft matrix for consultation (post referral) October 2012
Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: appendix B - draft scope for consultation (pre-referral) August 2010
Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban: appendix C - provisional matrix (pre-referral) August 2010